E7016 / Eisai  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
E7016 / Eisai
NCT01127178: Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors

Completed
1
12
US
E7016 + TMZ
Eisai Inc.
Solid Tumors
08/13
02/14

Download Options